CUSIP: 760273102
Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
42,837,925
-
Total 13F shares
-
36,516,609
-
Share change
-
+3,219,418
-
Total reported value
-
$266,618,743
-
Put/Call ratio
-
24%
-
Price per share
-
$7.30
-
Number of holders
-
69
-
Value change
-
+$7,114,924
-
Number of buys
-
30
-
Number of sells
-
44
Security key
760273102
Report period
Q4 2023
Institutions
69
Top holders
10
Reporting periods
Holder history for CUSIP 760273102
Recent filing periods:
Top shareholders of RPTX - Repare Therapeutics Inc. - Common shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q4 2023
As of 31 Dec 2023,
Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,516,609 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, Blue Owl Capital Holdings LP, Deep Track Capital, LP, ARK Investment Management LLC, Versant Venture Management, LLC, MPM ASSET MANAGEMENT LLC, Redmile Group, LLC, MPM BioImpact LLC, and Artal Group S.A..
This page lists
69
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2023 vs Q3 2023 Across Filers
| Investor |
Q3 2023 Shares |
Q4 2023 Shares |
Share Diff |
Share Chg % |
Q3 2023 Value $ |
Q4 2023 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.